Abstract
Pediatric epilepsy is a debilitating disease cluster that is much less researched than adult epilepsy. With approximately 30% of patients with pediatric epilepsy experiencing refractory seizures, novel treatment modalities are sometimes necessary to provide benefit. The use of marijuana, and more specifically cannabidiol, in people with seizures is much more broadly researched in adults compared with pediatric patients, although several recent review articles have been published. This article seeks to provide a pathophysiological basis for cannabidiol in epilepsy, discuss commercially available products and nonpharmaceutical marijuana, and review recent evidence in pediatric epilepsy.
[
Pediatr Ann
. 2023;52(10):e369–e372.]
Subject
Pediatrics, Perinatology and Child Health
Reference25 articles.
1. World Health Organization. Epilepsy. Updated February 9 2023. Accessed September 7 2023. https://www.who.int/news-room/fact-sheets/detail/epilepsy#:∼:text=Key%20facts most%20common%20neurological%20diseases%20globally
2. Cannabis, a complex plant: different compounds and different effects on individuals
3. Erowid. Cannabis. The Vaults of Erowid . Accessed September 7 2023. www.erowid.org/plants/cannabis/cannabis.html
4. Leafly. Cannabis 101. Accessed September 7 2023. www.leafly.com/news/cannabis-101
5. Cannabidivarin is anticonvulsant in mouse and rat